BNP Paribas Financial Markets Purchases 25,650 Shares of Edap Tms S.A. (NASDAQ:EDAP)

BNP Paribas Financial Markets raised its position in Edap Tms S.A. (NASDAQ:EDAP) by 111.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 48,650 shares of the medical equipment provider’s stock after buying an additional 25,650 shares during the quarter. BNP Paribas Financial Markets owned about 0.13% of Edap Tms worth $108,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Illumine Investment Management LLC bought a new position in Edap Tms in the 4th quarter valued at about $50,000. Jane Street Group LLC increased its holdings in Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73,361 shares during the period. Schonfeld Strategic Advisors LLC increased its holdings in Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after buying an additional 52,500 shares during the period. Finally, Rock Springs Capital Management LP boosted its stake in shares of Edap Tms by 1.5% in the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock valued at $3,518,000 after purchasing an additional 23,800 shares in the last quarter. 62.74% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Piper Sandler downgraded shares of Edap Tms from an “overweight” rating to a “neutral” rating in a research note on Thursday, May 15th. HC Wainwright restated a “buy” rating and issued a $19.00 price target on shares of Edap Tms in a research note on Friday, March 28th. Wall Street Zen assumed coverage on shares of Edap Tms in a research note on Thursday, May 15th. They issued a “hold” rating on the stock. Finally, Jefferies Financial Group restated a “hold” rating and issued a $2.00 price target (down from $8.00) on shares of Edap Tms in a research note on Friday, April 4th.

Edap Tms Stock Down 0.6%

NASDAQ:EDAP opened at $1.78 on Friday. The firm’s 50 day simple moving average is $1.82 and its 200 day simple moving average is $2.18. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms S.A. has a one year low of $1.26 and a one year high of $5.94. The company has a market cap of $66.56 million, a PE ratio of -2.74 and a beta of 0.13.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Thursday, May 15th. The medical equipment provider reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.04). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The business had revenue of $16.37 million for the quarter, compared to analyst estimates of $16.56 million. On average, research analysts anticipate that Edap Tms S.A. will post -0.6 earnings per share for the current year.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.